Development and Validation of an Rp-hplc Method for Simultaneous Determination of Ramipril and Amlodipine in Tablets

Overview

Journal J Pharm Anal

Specialty Chemistry

Date 2018 Feb 7

PMID 29403852

Authors

Shi-Ying Dai

Shi-Ting Qiu

Wei Wu

Chun-Mei Fu

Affiliations

Soon will be listed here.

Abstract

An rp-hplc method for the simultaneous determination of Ramipril (RP) and Amlodipine (AL) in tablets was developed and validated by Chinese Pharmacopoeia 2010. The linearity of the proposed method was investigated in the range of 0.01-0.25 mg/mL (=0.9998) for RP and 0.014-0.36 mg/mL (=0.9997) for AL. The limits of detection (LOD) were 0.06 μg/mL and 0.02 μg/mL for RP and AL, and the limits of quantitation (LOQ) were 0.2 μg/mL and 0.07 μg/mL, respectively. Some major impurities and degradation products did not disturb the detection of RP and AL and the assay can thus be considered stability-indicating.

References

Belal F, Gadkariem E, Abounassif M . A stability-indicating LC method for the simultaneous determination of ramipril and hydrochlorothiazide in dosage forms. J Pharm Biomed Anal. 2001; 24(3):335-42. DOI: 10.1016/s0731-7085(00)00474-x. View

Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G . Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000; 342(3):145-53. DOI: 10.1056/NEJM200001203420301. View

Baranda A, Mueller C, Alonso R, Jimenez R, Weinmann W . Quantitative determination of the calcium channel antagonists amlodipine, lercanidipine, nitrendipine, felodipine, and lacidipine in human plasma using liquid chromatography-tandem mass spectrometry. Ther Drug Monit. 2005; 27(1):44-52. DOI: 10.1097/00007691-200502000-00010. View

Zhu Z, Vachareau A, Neirinck L . Liquid chromatography-mass spectrometry method for determination of ramipril and its active metabolite ramiprilat in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2002; 779(2):297-306. DOI: 10.1016/s1570-0232(02)00398-7. View

Bhushan R, Gupta D, Singh S . Liquid chromatographic separation and UV determination of certain antihypertensive agents. Biomed Chromatogr. 2005; 20(2):217-24. DOI: 10.1002/bmc.557. View

Bangalore S, Kamalakkannan G, Parkar S, Messerli F . Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007; 120(8):713-9. DOI: 10.1016/j.amjmed.2006.08.033. View

Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R . Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial. Clin Ther. 2004; 26(9):1419-26. DOI: 10.1016/j.clinthera.2004.09.018. View

Rosenthal T, Gavras I . Fixed-drug combinations as first-line treatment for hypertension. Prog Cardiovasc Dis. 2006; 48(6):416-25. DOI: 10.1016/j.pcad.2006.03.003. View

Malacco E, Vari N, Capuano V, Spagnuolo V, Borgnino C, Palatini P . A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: the Val-Syst study. Clin Ther. 2003; 25(11):2765-80. DOI: 10.1016/s0149-2918(03)80332-6. View

10.

Bian Y, Yang H, Yang Z, Gao F, Zhang N, Xiao C . Amlodipine treatment prevents angiotensin II-induced human umbilical vein endothelial cell apoptosis. Arch Med Res. 2011; 42(1):22-7. DOI: 10.1016/j.arcmed.2011.01.012. View

11.

Hogan B, Williams M, Idiculla A, Veysoglu T, Parente E . Development and validation of a liquid chromatographic method for the determination of the related substances of ramipril in Altace capsules. J Pharm Biomed Anal. 2000; 23(4):637-51. DOI: 10.1016/s0731-7085(00)00342-3. View

12.

Dagenais G, Yusuf S, Bourassa M, Yi Q, Bosch J, Lonn E . Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation Study. Circulation. 2001; 104(5):522-6. DOI: 10.1161/hc3001.093502. View

13.

Mohammadi A, Rezanour N, Ansari Dogaheh M, Ghorbani Bidkorbeh F, Hashem M, Walker R . A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets. J Chromatogr B Analyt Technol Biomed Life Sci. 2006; 846(1-2):215-21. DOI: 10.1016/j.jchromb.2006.09.007. View

14.

Baranda A, Jimenez R, Alonso R . Simultaneous determination of five 1,4-dihydropyridines in pharmaceutical formulations by high-performance liquid chromatography-amperometric detection. J Chromatogr A. 2004; 1031(1-2):275-80. DOI: 10.1016/j.chroma.2003.11.019. View

15.

Suzuki M, Yamanaka K, Nabata H, Tachibana M . Long term effects of amlodipine on organ damage, stroke and life span in stroke prone spontaneously hypertensive rats. Eur J Pharmacol. 1993; 228(5-6):269-74. DOI: 10.1016/0926-6917(93)90060-4. View

16.

Arnold J, Yusuf S, Young J, Mathew J, Johnstone D, Avezum A . Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation. 2003; 107(9):1284-90. DOI: 10.1161/01.cir.0000054165.93055.42. View

17.

Rahman N, Azmi S . Spectrophotometric method for the determination of amlodipine besylate with ninhydrin in drug formulations. Farmaco. 2001; 56(10):731-5. DOI: 10.1016/s0014-827x(01)01093-x. View

18.

Siddiqui M, Plosker G . Fixed-dose combination enalapril/nitrendipine: a review of its use in mild-to-moderate hypertension. Drugs. 2004; 64(10):1135-48. DOI: 10.2165/00003495-200464100-00009. View

19.

Bonazzi D, Gotti R, Andrisano V, Cavrini V . Analysis of ACE inhibitors in pharmaceutical dosage forms by derivative UV spectroscopy and liquid chromatography (HPLC). J Pharm Biomed Anal. 1998; 16(3):431-8. DOI: 10.1016/s0731-7085(97)00075-7. View

20.

Zarghi A, Foroutan S, Shafaati A, Khoddam A . Validated HPLC method for determination of amlodipine in human plasma and its application to pharmacokinetic studies. Farmaco. 2005; 60(9):789-92. DOI: 10.1016/j.farmac.2005.06.012. View